Back to Results
First PageMeta Content
Intravenous immunoglobulin / Warranty / Biology / Medicine / CSL Behring / CSL Limited / Behring


[removed]Half Year Result 13 February 2013 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include forward looking statements about CSL Limited
Add to Reading List

Document Date: 2013-02-12 16:33:24


Open Document

File Size: 847,66 KB

Share Result on Facebook

Company

Product Groupings Pharma / Australian Securities Exchange / CSL Behring Product Sales / CSL Behring & Broadmeadow / Immunoglobulins Sales / CSL Limited / Normal IG / /

Continent

Asia / North America / Europe / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / Funding / Dividend Issuance / Reorganization / /

IndustryTerm

plasma products / manufacturing / healthcare regulations / /

MedicalCondition

influenza / /

Organization

European Union / /

Product

1H13 / /

SocialTag